Top related persons:
Top related locs:
Top related orgs:

Search resuls for: "Nasdaq Artificial Intelligence"


4 mentions found


Lauren Goodwin says investors should keep in mind that AI's eventual impact remains unknown. She said to invest thematically, focus on quality, and look at adjacent industries AI will rely on. Stocks like Nvidia and Microsoft — leaders in the AI space — have alone contributed to about 43% of the index's gains. "The excitement about generative AI has distracted investors from the possible risks of a looming recession," Goodwin said in a note on Tuesday. "The direct winners from AI technology may not be known yet.
Persons: Lauren Goodwin, Morgan Stanley, Goldman Sachs, Goodwin Organizations: Nvidia, Microsoft, New York Life Investments, Nasdaq Artificial Intelligence, Robotics, Intelligence, iShares Robotics, Companies, X Data, Digital Infrastructure ETF, Computing Fund
Anything with the words "artificial intelligence" is keeping Wall Street buzzing in 2023. So far this year, AI-focused funds such as the iShares Robotics & Artificial Intelligence Multisector and the ARK Autonomous Technology & Robotics , are higher by about 19% each. Take the the Global X Robotics & Artificial Intelligence fund, with about $1.6 billion in assets under management, that's up more than 16% this year. BOTZ YTD mountain Global X Robotics & Artificial Intelligence ETF's performance in 2023 C3.ai is the largest holding in the First Trust Nasdaq Artificial Intelligence and Robotics fund, according to Morningstar. But investors also get telecommunications company Ciena , optical equipment maker Topcon and defense technology company QinetiQ.
Each name in the list that follows has potential upside of about 35% or more, buy ratings from at least 60% of analysts and at least 10 analysts covering the stock. It has about 39% potential upside and buy ratings from almost 62% of the analysts covering it. Intellia Therapeutics , a company focused on gene-editing treatments, has upside potential of about 140% and buy ratings from 72% of its 27 analysts. Denali Therapeutics , which is focused on defeating neurodegenerative diseases, is close behind, with upside potential of 104% and buy ratings from almost 89% of its 18 analysts. Karuna Therapeutics , which specializes in schizophrenia treatments, holds the largest percentage of buy ratings, coming from 95% of its 20 analysts.
Much buzz has been generated around ChatGPT, an artificial intelligence chatbot that's gone viral and reportedly reached 100 million monthly active users in January. Its popularity has sparked much interest in artificial intelligence tech . "You really have to consider the role that artificial intelligence is going to play … it's made this quantum leap almost, you know, overnight. For investors considering investing in AI, CNBC Pro has screened two ETFs for stocks: the $1.59 billion Global X Robotics & Artificial Intelligence ETF and the First Trust Nasdaq Artificial Intelligence & Robotics ETF, which tracks the Nasdaq CTA Artificial Intelligence and Robotics Index. Voice AI platform SoundHound also got a 100% buy rating, and analysts put its potential average upside at 31%.
Total: 4